SS

Saji Shanty

Active Director Director DIN 07458504
DIN 07458504 First appointment Oct 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Saji Shanty

Data last updated:

Saji Shanty is a Director at Essbrains Pharma Private Limited (since 2015). The company operates in Healthcare. Essbrains Pharma Private Limited reported revenue of ₹16.9 Lakh (FY 2025).

DIN 07458504
Primary Designation Director
Industry Healthcare
First Appointment 01 Oct 2015
Oldest Company Age 13 yrs
Largest company Essbrains Pharma Private Limited · ₹16.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Essbrains Pharma Private Limited U24233KL2013PTC034952
Director01 Oct 20152013₹16.9 Lakh (FY 2025)Active

Board colleagues of Saji Shanty

Directorship timeline

Open interactive timeline →
Essbrains Pharma Private Limited
Premium access

Shareholding and investment profile for Saji Shanty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saji Shanty

Saji Shanty currently holds 1 directorship: Essbrains Pharma Private Limited (Director, since 01 Oct 2015, revenue ₹16.9 Lakh (FY 2025)).

Saji Shanty was first appointed on 01 Oct 2015 as Director at Essbrains Pharma Private Limited.

The current boards of Saji Shanty's companies include Pramod Parameswaran (Essbrains Pharma Private Limited), Saji Jose (Essbrains Pharma Private Limited), Sreejith Sreekumar (Essbrains Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available